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a b s t r a c t
Speciﬁcation and maturation of insulinþ cells accompanies a transition in expression of Maf family of
transcription factors. In development, MafA is expressed after speciﬁcation of insulinþ cells that are
expressing another Maf factor, MafB; after birth, these insulinþ MafAþ cells stop MafB expression and
gain glucose responsiveness. Current differentiation protocols for deriving insulin-producing β-cells from
stem cells result in β-cells lacking both MafA expression and glucose-stimulated insulin secretion.
So driving expression of MafA, a β-cell maturation factor in endocrine precursors could potentially
generate glucose-responsive MafAþ β cells. Using inducible transgenic mice, we characterized the ﬁnal
stages of β-cell differentiation and maturation with MafA pause/release experiments. We found that
forcing MafA transgene expression, out of its normal developmental context, in Ngn3þ endocrine
progenitors blocked endocrine differentiation and prevented the formation of hormoneþ cells. However,
this arrest was reversible such that with stopping the transgene expression, the cells resumed their
differentiation to hormoneþ cells, including α-cells, indicating that the block likely occurred after
progenitors had committed to a speciﬁc hormonal fate. Interestingly, this delayed resumption of
endocrine differentiation resulted in a greater proportion of immature insulinþMafBþ cells at P5,
demonstrating that during maturation the inhibition of MafB in β-cell transitioning from insulinþMafBþ
to insulinþMafB stage is regulated by cell-autonomous mechanisms. These results demonstrate the
importance of proper context of initiating MafA expression on the endocrine differentiation and suggest
that generating mature InsulinþMafAþ β-cells will require the induction of MafA in a narrow temporal
window to achieve normal endocrine differentiation.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Insulinþ cells speciﬁed during pancreatic development undergo
a maturation process by transitioning from being MafBþMafA
Insulinþ to MafBþMafAþ Insulinþ and then to MafBMafAþ Insu-
linþ cells (Artner et al., 2006, 2010; Nishimura et al., 2006). The
induction of MafA after the initiation of insulin expression indicates
that MafA regulates β-cell maturation/function rather than β-cell
speciﬁcation. This is consistent with MafA knockout mice having
normal-looking islets at birth but developing β-cell dysfunction
and hyperglycemia gradually with age (Artner et al., 2010; Zhang
et al., 2005). Both MafB and MafA bind Maf Response Elements
(Nishimura et al., 2006), and most MafA-regulated genes are ﬁrst
regulated by MafB during embryonic development (Artner et al.,
2010). Yet β-cell mass is reduced only in MafB-deﬁcient and not
MafA knockout mice (Artner et al., 2007, 2010; Nishimura et al.,
2008). In addition to demonstrating a critical role of MafA in β-cell
maturation, these observations emphasize a unique temporal role
for Maf factors during commitment to β-cell fate and the impor-
tance of correct context of their initiation on differentiation of
β-cells.
The goal of β-cell replacement therapy for type 1 diabetes is to
achieve insulin independence by restoring the functional β-cell
mass. Yet differentiation protocols for deriving functional β-cells
from embryonic stem (ES) cells and induced pluripotent stem (iPS)
cells (D’Amour et al., 2006; Kroon et al., 2008; Maehr et al., 2009;
McKnight et al., 2010; Rezania et al., 2012) still only result in
immature cells with limited insulin content and lacking glucose-
stimulated insulin secretion (GSIS) (Basford et al., 2012; Mfopou
et al., 2010). To overcome these limitations it is vital to understand
how insulin-producing cells are formed during embryonic devel-
opment and how they mature into glucose-responsive β-cells.
It is likely that during ES cell differentiation protocols inap-
propriate control of the initiation of Maf factor expression pre-
ventsMafA induction and the maturation of insulinþ cells (Basford
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et al., 2012; D’Amour et al., 2006). One suggestion to generate
glucose responsive β-cells has been to force MafA expression
during the differentiation of ES and iPS cells. Our data on the
detrimental effects of mistimed MafA expression in early Pdx1þ
pancreatic progenitors, such that their proliferation and the
differentiation of endocrine cells were impaired (Nishimura
et al., 2009), demonstrate the narrowness of the effective window
for initiation of MafA expression. To avoid these detrimental
effects in Pdx1þ progenitors (Nishimura et al., 2009), one possibility
would be to force MafA expression upon initiation of endocrine
differentiation to force immature insulinþ cells into “mature”
insulinþMafAþ cells.
Here we demonstrate that out-of-context MafA expression in
Ngn3þ (Neurog3þ Mouse Genome Informatics) endocrine pro-
genitors does not affect their survival but blocks their differentia-
tion and the formation of hormoneþ cells. This block occurs after
progenitors commit to a speciﬁc hormone-expressing fate. Impor-
tantly, removing MafA expression re-engages the ‘normal’ differentia-
tion program in these cells, thereby driving committed precursors
into hormoneþ cells. Our experimental approach provides an impor-
tant means to evaluate the effects of the on/off timing of MafA
expression as a driver of differentiation/maturation of β-cells. Using
this approach, we show the importance of the proper context of
initiating MafA expression for endocrine differentiation and a role of
cell-intrinsic mechanisms in postnatal suppression of MafB expres-
sion in insulinþ cells.
Materials and methods
Mice
All animal procedures were approved by Joslin Diabetes Center
IACUC. A line of tetracycline-inducible transgenic mice driving
expression of Myc-tagged human MafA (TetOMafA) under the
control of pTRE-Tight promoter (Clontech) (Nishimura et al.,
2009) (expressing 5 copies of transgene) was used. TTendo mice
result from breeding Ngn3Cre BAC mice (Schonhoff et al., 2004)
with ROSA26 lox-stop-lox rtTA-IRES-EGFP mice (Rosa26rtTA) (Belteki
et al., 2005) and our TetOMafA mice. For induction, 1 g/L Doxycy-
cline (Sigma) was added in the drinking water containing artiﬁcial
sweetener; water was changed every second day.
Immunohistochemistry
Pancreases were ﬁxed in 4% paraformaldehyde, processed
through sucrose before enrobing in OCT and frozen. Immunostain-
ing (see Supplementary methods) was done on frozen sections.
Images were taken either with Zeiss Axiocam or confocally Zeiss
LSM 710 microscopes. Cell area quantiﬁcation was performed with
Volocity (PerkinElmer). Quantiﬁcation of each antigen was per-
formed on ﬁve sections separated by at least 50μm for at least
3 mice per group.
Antibodies: rabbit anti-MafA 1:100 (Bethyl, Montgomery, TX),
rabbit anti-MafB 1:100 (Bethyl), rabbit anti-Myc 1:200 (Cell
Signaling, Danvers, MA), guinea pig anti-Insulin 1:100 (Linco,
Billerica, MA), mouse anti-Glucagon 1:100 (Sigma, Saint Louis,
MO), mouse anti-Ngn3 1:100 (Hybridoma Bank, Iowa City, IA),
mouse anti-Pdx1 1:1000 (Millipore, Temecula, CA), rabbit anti-GFP
1:100 (Invitrogen, Eugene, OR), biotinylated-DBA lectin (Vector,
Burlingame, CA) and others were described earlier (Nishimura
et al., 2009). In our hands, immunostaining with both
Chromogranin-A 1:1000 (Immunostar, Hudson, WI) and cocktail
of Ghrelin, Somatostatin, PP antibodies were technically incompa-
tible, as was GFP co-staining with Myc-tag, MafA and MafB.
To overcome these incompatibilities, adjacent sections were used
with different combinations of antibodies.
qRT-PCR and genotyping
Total RNA from 4 control and 3 TTendo P0 pancreases (DOX-ON
from E7.5 to P0) was prepared using Trizol RNA isolation reagent
followed by Qiagen RNA easy mini cleanup kit. cDNAs from
individual RNA samples were used in quantitative RT-PCR. The
results were quantiﬁed using comparative threshold cycle method
(ΔΔCT), following normalizing expression of different genes with
the expression of control 18S rRNA. Forward and Reverse primers
used in the study are described in the Supplementary Table 1. PCR
primers designed in 3' un-translated region (UTR) of MafA detect
expression of only endogenous MafA, while those amplifying the
coding sequence (cds) quantify both endogenous and TetOMafA
transgene.
Genotyping: Genomic DNA was extract from tail snip and used
in PCR reaction to determine genotypes of different animals.
Primers used in the PCR include MafA-transgene forward 5′
GTGCCAACTCCAGAGCCAGGTG3′ and reverse 5′GTTTCAGGTT-
CAGGGGGAGGTGTG3′; Cre forward 5′CCGGGCTGCCACGACCAA3′
and reverse 5′GGCGCGGCAACACCATTTTT3′; and rtTA forward 5′
TGCCGCCATTATTACGACAAG3′ and reverse 5′CCGCGGGGAGAAAG-
GAC3′. Additionally, genotyping to conﬁrm wild type or knock-in
ROSA26 allele were performed as suggested by Jax Lab.
Western blot analysis
Adult control and TTendo mice, not exposed to DOX from
conception to adult, were given DOX for 5 days in drinking water
prior to sacriﬁce. Islets were isolated with collagenase digestions
and whole islet protein extracts prepared (Kondo et al., 2009). Cell
extracts of 293T cells infected with MafA adenovirus were pre-
pared as positive controls. Protein extracts (20 μg) were boiled for
5 min in the presence of β-mercaptoethanol and resolved on 10%
SDS-PAGE (polyacrylamide gel electrophoresis), transferred to
PVDF membranes and probed with MafA (1:2000) (Nishimura
et al., 2006), actin was used as a loading control. Primary
antibodies were diluted in Tris-buffered saline containing 0.2%
Tween 20 (TBST). Membranes were washed in TBST and incubated
with either anti-rabbit or anti-mouse secondary antibodies con-
jugated to horseradish peroxidase. Membranes were further
processed using either chemiluminescence SuperSignal West Dura
reagent or West Dura Femto (Pierce).
Results
Mistimed expression of endocrine maturation factor MafA in Ngn3þ
cells prevents access to endocrine ontogeny
We generated Triple Transgenic mice to induce MafA expression
in progeny of endocrine progenitors (TTendo) by breeding Ngn3Cre
mice (Schonhoff et al., 2004) with ROSA26 lox-Stop-lox rtTA-IRES-
EGFP mice (Rosa26rtTA) (Belteki et al., 2005) and TetOMafA mice
(Nishimura et al., 2009) (Fig. 1A). In the presence of Doxycycline
(DOX), reverse tetracycline transactivator (rtTA) inducedMyc-tagged
MafA transgene (TetOMafA, subsequently referred to as MafAMyc)
expression in the progeny of Ngn3þ cells. Independent of DOX,
Cre-mediated excision of the lox-Stop-lox cassette should mark
endocrine progenitors and their progeny with GFP.
MafAMyc expression in the progeny of endocrine progenitors
throughout embryonic development [DOX-ON from before Ngn3
expression (E.7.5) until P0] had no effect on the gross appearance
of P0 TTendo pancreas, but it dramatically reduced the number of
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insulin- and glucagon-expressing, as well as Pdx1-expressing cells
(Fig. 1F–I). During pancreatic development, MafA expression is
initiated after a cell is already expressing insulin (Nishimura et al.,
2006). However, many MafAþ cells in P0 TTendo pancreas did not
express insulin (nor glucagon) (Fig. 1F–G). α-Myc and α-MafA
antibodies were used to detect MafAMyc (transgene) and total
MafA (endogenous and transgene) expression, respectively. Ana-
lysis of consecutive sections of TTendo P0 pancreas showed expres-
sion of lineage marker GFP, Myc and MafA in the same area
(Fig. 1M–O), suggesting that MafAþ InsGlu cells (Fig. 1F,G, O)
were expressing the MafAMyc transgene; consistent with the
presence of many hormone Mycþ cells in the TTendo P0 pancreas
(Fig. 1I). qRT-PCR data from P0 control and TTendo pancreases
showed a dramatic reduction in endogenous MafA (reduced levels
of MafA 3’UTR PCR product) but a 5.7-fold increase in total MafA
(MafA cds product) expression (Table 1) demonstrating that the
MafA expression seen in the P0 pancreas (Fig. 1) results mainly
from the MafAMyc transgene expression. MafAMyc expression in the
endocrine progenitor inhibited the proportion of insulin and glucagon
expressing cells in P0 TTendo pancreas by 80% (Fig. 1P). However, this
inhibition did not alter the relative proportion of α- and β-cells (20%
and 80%, respectively) in either group (Fig. 1Q).
Mistimed MafA expression in endocrine progenitors did not trigger
altered fate selection
We next examined whether the MafAMyc-mediated inhibition
of differentiation altered the fate selection of the endocrine
progenitors. Consistent with staining and quantiﬁcation results
(Fig. 1), by qPCR expression of insulin and glucagon mRNA was
signiﬁcantly reduced in P0 TTendo pancreas, and so was the
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Fig. 1. Inducing MafA expression in endocrine progenitors selectively inhibited endocrine differentiation. (A) Schematic of alleles used to generate the TTendo triple transgenic
mice for DOX-dependent induction of MafAMyc in Ngn3þ cells and their progeny. (B–I) P0 pancreas from TTendoP0 (DOX-ON [yellow in schematic] from E7.5 to P0) and control
littermates immunostained for MafA, Pdx1, transgene MafAMyc, insulin and glucagon. MafAMycþ hormone cells are likely the progeny of endocrine progenitors (GFPþ) as
shown on consecutive sections of control (J–L) and TTendoP0 (M–O) pancreas stained for GFP, MafA, Myc (green) and insulin (red). In TTendo P0 pancreas cells corresponding to
GFPþ cells (M) also express transgene Myc (N) and MafA (O). (P) At P0, TTendo had signiﬁcantly reduced insulinþ or glucagonþ areas compared to control littermates.
(Q) Relative proportions (%) of insulinþ and glucagonþ cells in P0 islets were comparable in all groups. Mean7s.e.m., n¼3 animals per group. npo0.05, nnpo0.001. Images
of control animals in (B–E) were from double transgenic Ngn3Cre/þ ;Rosa26rtTA/þ , while those for (J–L) were from double transgenic TetOMafAMyc;Rosa26rtTA/þ .
Table 1
Quantitative RT-PCR results showing relative expression of transcription factors
and hormone genes in control and TTendo P0 pancreas.
Genes Control7SEM TTendo7SEM P-value
MafA cds 1.070.34 5.7370.87 2.00E03
MafA (endogenous) 1.070.29 0.0670.01 0.04
Insulin 1.070.22 0.0270.01 0.01
Glucagon 1.070.25 0.0670.03 0.03
Somatostatin 1.070.10 0.0270.01 3.00E04
Neurog3 1.070.18 0.7470.14 0.32
Insm1 1.070.14 0.4470.03 0.02
NeuroD1 1.070.14 0.1770.02 4.00E03
MafB 1.070.23 0.1970.04 0.03
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expression of somatostatinmRNA (Table 1). By microarray analysis,
TTendo P0 pancreas had 8–12 fold lower expression of genes for
hormones insulin, glucagon and somatostatin and 2–5 fold lower
Peptide YY, Ghrelin and Pancreatic Polypeptide than control but no
signiﬁcant difference in expression of multiple acinar and duct-
enriched genes (Supplementary Table 2). As seen in P0 pancreatic
sections stained using a cocktail of antibodies against glucagon,
somatostatin and PP, the number of non-β-cells was also reduced
(Fig. 2A,B). No differences in ductal (DBAþ) and acinar (amylaseþ)
areas were seen in pancreas from control and TTendo littermates
(Fig. 2C–F), consistent with no change in the expression of several
acinar and ductal genes in TTendo P0 pancreas (Supplementary
Table 2). In TTendo pancreas large numbers of non-insulin-
expressing cells were seen in “islet–like” areas surrounded by
normal exocrine cells (Fig. 2C,D). The proportion of apoptotic cells
was comparable to controls (data not shown). These observations
suggest that the reduction in hormoneþ cells in TTendo pancreas
(Fig. 1) did not result from endocrine precursors being diverted
into other fates (acinar or ductal) when unable to progress down
the endocrine lineage and that the hormoneMafAMycþ cells can
coalesce to form “endocrine” clusters (Figs. 1,2).
To evaluate whether the inhibition of endocrine differentiation
was due to unusually high MafA expression from the transgene,
the level of MafAMyc expression was determined. In P0 TTendo
pancreas total MafA mRNA levels (MafA cds) were only 5.7-fold
greater than control (Table 1). In pancreas, MafA expression is
restricted to β-cells. Hence, a 5.7-fold increase in MafA message in
P0 TTendo pancreatic RNA was still less than the levels of endogen-
ous MafA in adult islets/β-cells (10-fold higher than at birth)
(Aguayo-Mazzucato et al., 2011). Furthermore, isolated islets from
adult TTendo mice after receiving DOX for 5-days had only 2–4 fold
greater total MafA protein levels than control (Fig. 2G). When we
introduced the same transgene in insulinþ cells (TTins) by breeding
Ins2Cre (Postic et al., 1999) with Rosa26rtTA and TetOMafA mice, we
found that continued induction of MafAMyc expression [DOX-ON
from before speciﬁcation of insulinþ cells until birth (E7.5 to P0)]
did not prevent islet formation nor insulin-expressing β-cells
(Fig. 2H,I), showing that MafAMyc was expressed at a level that
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Fig. 2. Mistimed MafA expression in endocrine progenitors does not alter fate selection. (A,B) P0 pancreatic sections immunostained with antibody cocktail against glucagon,
somatostatin and PP (brown, peroxidase staining) showing an overall reduction in hormoneþ cells in TTendoP0 compared to control littermates. Magniﬁcation bar¼20 μm.
(C–F) Amylaseþ and DBAþ duct (green) areas were not affected in TTendoP0 pancreas that has reduced insulinþ (red) cells in islet-like structure. (G–I) Transgene expression
level was not detrimental to endocrine cells. (G) Western blot analysis of extracts from TTendo islets isolated from adult mice sacriﬁced after receiving DOX for 5 days show a
2–4 fold increase in total MafA protein compared to extracts from comparable control islets; 293T cells infected with Adeno-MafA (AdMafA) virus as positive control. (H–I)
Induction of MafAMyc (green) expression in insulinþ (red) cells in TTIns (InsCRE;ROSA26rtTA;TetOMafA) animals receiving DOX from E7.5 until sacriﬁce at P0 did not affect
the formation of insulinþ cells. Images of control animals in (A,C,E) were from double transgenic Ngn3Cre/þ ;Rosa26rtTA/þ , while those for (H) were from double transgenic
InsCre/þ ;Rosa26rtTA/þ . Magniﬁcation bar¼20 μm.
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per se did not inhibit insulinþ cell formation. Thus, the loss of
hormoneþ cells in TTendo pancreas likely resulted from the mis-
timed MafA expression inhibiting a speciﬁc earlier step(s) in
endocrine differentiation.
Expression of MafA in endocrine progenitors does not affect the
formation of endocrine progenitors but inhibits completion of
endocrine differentiation
By varying the timing of DOX administration, we could deﬁne
when MafA expression in Ngn3 expression-enabled endocrine
progenitors becomes detrimental to their differentiation. After
receiving DOX during secondary transition (from E12.5 to E15.5
with sacriﬁce at E15.5 or from E13.5 to P0 with sacriﬁce at P0)
TTendo embryos had dramatically reduced number of endocrine cells
(Fig. 3A–F) compared to corresponding controls. These observations
show that precocious MafA expression in Ngn3þ cells potentially
affects the steps regulating their formation and differentiation into
endocrine cells.
We next examined whether MafAMyc expression in endocrine
progenitors altered formation of endocrine progenitors by affect-
ing lateral inhibition. The E15.5 pancreases from controls and
TTendo mice had comparable number of Ngn3þ cells (Fig. 3G,H).
Quantiﬁcation of Ngn3þ and MafAMycþ cells from E15.5 controls
and TTendo pancreases showed comparable number of Ngn3þ and
Mycþ cells in TTendo and control E15.5 pancreases. Furthermore,
similar number of Myc- and of Ngn3-expressing cells in TTendo
pancreas suggest that most, if not all, Ngn3þ cells are also Mycþ
(Supplementary Fig. 1). The presence of many MafAMycþ cells in
TTendo embryos at E15.5 (Fig. 3C) indicated that the Ngn3 promoter
was sufﬁciently active to induce Cre-mediated excision of the Stop
cassette and that the MafAMycþ progeny of Ngn3þ cells (GFPþ , Mycþ
cells) survived at least until birth (Figs. 1I,M,N and 3J). Thus although
forced MafAMyc expression inhibited endocrine differentiation, it did
I
Fig. 3. MafA transgene expression in endocrine progenitors during secondary transition dramatically inhibited endocrine differentiation but did not affect the formation of
Ngn3þ or ChrgAþ cells. (A–D) After DOX exposure from E12.5 to E15.5, TTendo E15.5 pancreas had large numbers of Mycþ and MafAþ cells that did not express insulin,
demonstrating inhibition of endocrine differentiation. MafA, Myc (green) and insulin (red) DAPI (blue). (E–F) Similarly, after DOX from E13.5 to P0, TTendo P0 pancreas had
dramatically reduced insulinþ and Pdx1þ cells compared to corresponding controls. Pdx1 (green), insulin (red) and nuclei (DAPI, blue). Magniﬁcation bar¼20 μm. (G,H)
After DOX from 7.5 until sacriﬁce at E15.5, TTendo E15.5 pancreas shows that the speciﬁcation of Ngn3þ cells was not inhibited by MafAMyc expression compared to control.
Ngn3 (green), Ins (red) and DAPI (blue). (I,J) Transgene MafAMyc expression in endocrine progenitors resulted in endocrine cells expressing chromograninA (ChrgA) but not
insulin. In control P0 pancreas (I) cells coexpress (pink) ChrgA (red) and insulin (gray pseudo color) but in TTendoP0 pancreas (J) many ChrgA (red) cells express only the
transgene (Myc, green) and no insulin. DOX-ON from E7.5 to P0. (K) Quantiﬁcation of ChrgAþ cells as % of pancreatic area; n¼3. Images of control animals in (A,B,E) were
from double transgenic Ngn3Cre/þ;Rosa26rtTA/þ , while those for (I) were from double transgenic TetOMafAMyc;Rosa26rtTA/þ . Magniﬁcation bar¼20 μm.
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not affect the formation of additional endocrine progenitors nor
inhibit the survival of endocrine progeny.
To determine if the transgene expression completely blocked or
altered the endocrine differentiation program, we examined the
expression of chromogranin-A (ChrgA) as a marker of all endocrine
cell-types (Fig. 3I,J). At birth, control pancreas had numerous
insulinþChrgAþ cells and a few insulinChrgAþ that represent the
other hormoneþ cells. As predicted from the loss of hormoneþ cells in
P0 TTendo pancreas (Fig. 1), many ChrgAþ cells wereMafAMycþ insulin
and only a few were MafAMycinsulinþ cells (Fig. 3J). Images showing
expression of Myc, insulin and chromogranin-A in separate channels
(Supplementary Fig. 2) clearly demonstrate the presence of ChrgAþ
InsMycþ cells in P0 TTendo pancreas. Quantiﬁcation of relative
pancreatic area of ChrgAþ cells showed comparable proportions of
ChrgAþ cells in both control and TTendo littermates (Fig. 3K). Micro-
array results (Supplementary Table 2) from P0 TTendo and control
pancreases showed a reduction in expression of some secretory
granule genes like Synaptotagmin-like 4, Secretogranin III and chro-
mograninB in TTendo pancreas, but the expression of ChrgA and
Synaptophysin were not altered. Furthermore, qRT-PCR and micro-
array data (Table 1, Supplementary Table 2) showed a slight reduction
in Ngn3 expression but signiﬁcant reductions in expression of endo-
crine hormone genes, downstream targets of Ngn3, Glut2 (2.34-fold;
Mean values 579 vs 247 p¼4.30E-04), and key endocrine transcription
factors. We interpret these results to suggest that all lineage-marked
endocrine progenitors expressing MafAMyc maintain their endocrine
phenotype, progress down the endocrine lineage and turn-on some
endocrine speciﬁc genes but cannot complete the differentiation
process. A consequence of such block in endocrine differentiation
was that at birth TTendo pups with milk in their stomach were
hyperglycemic compared to similar wild type control littermates
[blood glucose 111718 (n¼3) vs 6472 (n¼7) mg/dl, p¼0.003].
Forcing MafAMyc expression blocks differentiation of endocrine
progenitors after their commitment to a speciﬁc
hormone-expressing fate
Since transgene expression was regulated by DOX, we could
examine whether stopping MafAMyc expression in hormone
MafAMycþ cells will result in these cells resuming their endocrine
differentiation program. Two groups of pregnant females were
given DOX from E7.5; in one, DOX was stopped at E15.5 to reverse
the differentiation block (TTendoE15.5Rev animals), while in the
other, DOX was continued until birth (TTendoP0 animals); pups
were sacriﬁced at birth. As expected, continued expression of
transgene from E7.5 to P0 dramatically reduced the insulinþ cells
but had many MafAMycþ insulin cells in the pancreas (Fig. 4E–H).
MafB and Pdx1-expressing cells, normally expressed early in the
differentiation of insulinþ cells, were also reduced in number.
Other key endocrine transcription factors (Supplementary Table 2)
as well as the expression of cell adhesion molecules E-Cadherin
and N-Cadherin (Supplementary Fig. 3) were down-regulated in
P0 TTendo pancreas. These observations suggest that TTendo animals
can form endocrine cell aggregates that are similar but not
identical to the endocrine cell aggregates seen in control pancreas.
Stopping the MafAMyc expression by removing DOX at E15.5
(TTendoE15.5Rev) resulted in a remarkable restoration of insulinþ
cells by P0 (Fig. 4I–L). Some insulinþ cells expressed MafA, many
expressed MafB and Pdx1, and the expression of E-Cadherin
and N-Cadherin was recovered. We interpret these ﬁndings as
Myc Ins DAPI  MafA Ins                    MafB Ins Pdx1 Ins
P0
Ins Glu DAPI
Control
C
on
tr
ol
TT endo P0
TT
en
do
P0
TT endoE15.5 Rev
TT
en
do
E1
5.
5 
R
ev
0
1
2
3
4
5
%
 E
nd
oc
rin
e 
ar
ea
glucagon
insulin
TTendo
E15.5Rev 
*
*
0
20
40
60
80
100
120
%
 In
su
lin
 &
 G
lu
ca
go
n 
C
el
ls
% glucagon
% insulin
TTendo
E15.5Rev 
Fig. 4. Reversible inhibition of endocrine differentiation by transgene MafAMyc expression in endocrine progenitors. P0 pancreases from control, TTendo P0 (DOX-ON from E7.5
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TTendoE15.5Rev had signiﬁcantly increased insulin or glucagon areas compared to TTendoP0 (Fig. 1P) but were still reduced compared to control littermates. (Q) Relative
proportions (%) of insulin and glucagon cells in P0 islets were comparable in all groups. Mean7s.e.m., n¼3 animals per group. npo0.05, nnpo0.001. Images of control
animals in (A–D, M) were from double transgenic TetOMafAMyc;Rosa26rtTA/þ . Magniﬁcation bar¼20 μm.
K.H. Hu He et al. / Developmental Biology 385 (2014) 2–12 7
evidence of resumption of the normal pancreatic development and
β-cell differentiation program.
The competence of pancreatic epithelium to form α-cells is
primarily restricted to before E14.5 (Johansson et al., 2007). Hence,
if the transgene expression blocked endocrine differentiation
before commitment to a speciﬁc hormonal fate, releasing the
block after E15.5 should lead to a relatively selective, large-scale
reduction in α-cells. However, stopping MafA transgene expres-
sion from E15.5 (TTendoE15.5Rev) resulted in restoration of both
insulin and glucagon cells (Fig. 4M–O). At P0, insulinþ and
glucagonþ cells in TTendoE15.5Rev were more numerous than in
TTendoP0. Forced MafAMyc expression in endocrine progenitors
reduced both α- and β-cell volumes to 20% of control in TTendoP0
(80% inhibition) (Fig. 1P) but only to 60% of control in TTendo E15.5
Rev animals (40% inhibition) (Fig. 4P). However, this inhibition did
not alter the relative proportion of α- and β-cells (20% and 80%,
respectively) in either group (Figs. 1Q, 4Q). Thus, the initiation of
endocrine differentiation after E15.5 did not result in the expected
preferential reduction in α-cells.
To conﬁrm that stopping DOX in TTendo E15.5 Rev triggered a
resumption of the endocrine differentiation of MafAMycþhormone
cells, we examined the proportion of lineage-marked cells
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Fig. 5. MafA transgene inhibited endocrine differentiation after hormonal fate commitment. (A–F) In P0 TTendoE15.5Rev pancreas resumption of endocrine differentiation
after stopping DOX at E15.5 resulted in formation of all hormonal cell types. Adjacent sections stained with cocktail of Ghrelin, Somatostatin, PP antibodies (green), insulin
(red) and nuclei (DAPI, blue), or GFP (green) with insulin (red) or glucagon (red). Magniﬁcation bar¼20 μm. (G) Quantiﬁcation of InsþGFPþ cells (lineage-marked cells) and
InsþGFP (cells that escaped Ngn3-Cre-mediated excision) as proportion of total insulin cells. InsþGFPþ cells were 80% of total GFPþ cells in both control and
TTendoE15.5Rev. (H) Similar quantiﬁcation for glucagonþ cells showed 20% GFPþ cells expressed glucagon. Control NR and TTendoE15.5Rev pancreas had similar proportions
of GFP-marked insulin and glucagon cells. GFPþhormone cells were not detected in TTendoE15.5Rev animals. Ctrl NR¼ double transgenic Ngn3Cre/þ;Rosa26rtTA/þ animals.
Mean7SEM, n¼3 animals per group. (I) Schema summarizing the inhibition of endocrine differentiation by mistimed MafA expression and the consequences of removing
DOX on hormone expression in TTendo animals.
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expressing hormones. In addition to Myc, GFP expression in TTendo
pancreas marks the progeny of endocrine progenitors. However,
unlike DOX dependent MafAMyc expression, GFP expression from
Rosa26 promoter-driven rtTA-IRES-EGFP transcript should be
detected in all progeny of Ngn3þ cells upon the excision of the
stop cassette regardless of presence of DOX. In TTendo pancreas at
E15.5 and P0 (Figs. 1, 3), MafAMycþhormone cells express lineage
marker GFP (Fig. 1 and data not shown); we expect that even after
stopping DOX at E15.5 (TTendo E15.5 Rev), all progeny of Ngn3þ cells
would retain GFP expression. In adjacent pancreatic sections from
TTendoE15.5Rev or control littermates bearing Ngn3Cre and Rosa26rtTA
transgenes (Control NR) immunostained for different hormones and
GFP (Fig. 5), the majority of GFPþ cells expressed either insulin or
glucagon (Fig. 5C–F). Ngn3Cre BAC-based lineage marking was highly
efﬁcient with 90% of insulinþ and glucagonþ cells in P0 pan-
creases from TTendoE15.5Rev and NR control littermates expressing
GFP (Fig. 5G,H).
Many GFPþ Ins and Mycþhormone cells were seen in TTendo
P0 pancreas in the presence of DOX (Fig. 1), and similar Mycþ Ins
cells were seen at E15.5 (Fig. 3). If the transgene expression
irreversibly blocked endocrine differentiation of these cells, the
removal of DOX at E15.5 should prevent these lineage marked cells
to express either hormone. The absence of a large pool of
GFPþhormone cells in TTendoE15.5Rev (Fig. 5D,F–H) is evidence
of the resumption of differentiation in MafAMycþhormone cells
present at E15.5. Furthermore, this observation rules out the
possibility that Ngn3þ cells speciﬁed after stopping DOX were
the sole source of new endocrine cells in TTendoE15.5Rev pancreas.
We interpret the unchanged proportion of glucagonþ cells (Figs. 4,5)
and the absence of signiﬁcant numbers of hormoneGFPþ cells
(Fig. 5) as suggesting that forced MafA expression in endocrine
progenitors inhibits their differentiation at a stage after the pro-
genitor commits to a speciﬁc endocrine fate but before induction of
hormone expression (Fig. 5I). We propose that during embryonic
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Fig. 6. Delaying endocrine differentiation resulted in more immature β-cells. (A–F) Delaying endocrine differentiation until E17.5 (DOX-ON from E7.5 to E17.5) resulted in all
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development as the Ngn3þ endocrine progenitors became speciﬁed,
they turned-on the expression of MafAMyc but the endocrine
progenitor continued their differentiation program, initiated expres-
sion of some endocrine genes and committed to one of the
hormonal fates, but at this stage the transgene expression blocked
their further progression to hormoneþ endocrine cells (Fig. 5I).
Cell-autonomous mechanisms are integral to maturation of insulin-
producing cells
During a maturation stage of development, insulinþ cells
progress from mostly expressing MafB (90%) at end of gestation
to solely expressing MafA by adult (Artner et al., 2010; Artner et al.,
2006; Nishimura et al., 2006). This switch after birth suggests the
loss of MafB expression is signaled by parturition and/or the
altered nutritional state. Since MafAMyc reversibly blocked endo-
crine differentiation (Figs. 4,5), delaying the resumption of endo-
crine differentiation may be used to dissect the relative
contributions of cell-autonomous and postnatal extrinsic signals
to the loss of MafB expression. DOX-dependent regulation of
TetOPdx1 expression by Pdx1tTA requires 24 h to turn on/off
transgene expression (Hale et al., 2005). Robustly insulinþ cells
are ﬁrst detected at E12.5, so assuming that effective changes in
MafAMyc expression also requires 24 h, providing DOX until E17.5
would delay differentiation of committed insulin precursors
between 1 (cells speciﬁed late at E17.5) and 6 days (cells speciﬁed
early at E12.5). A cohort of pregnant dams received DOX from E7.5
until E17.5, and their pups were sacriﬁced at P5 (TTendoP5 and
corresponding NR controls). DOX removal in late gestation
relieved the block in differentiation, and the endocrine progeny
(GFPþ) differentiated into insulin, glucagon and other hormones-
expressing cells (Fig. 6A–F). However, in contrast to NR controls,
TTendoP5 pancreas had higher proportion of insulinþ cells expres-
sing MafBhigh (10.771.2% NR controls vs. 28.272.1% TTendoP5
p¼0.002) (Fig. 6H,K), occasional Pdx1insulinþ cells (Fig. 6I,L),
few MafAþ insulinþ cells, and lower staining intensity of endogen-
ous MafA (Fig. 6G,J). These results are consistent with the delayed
endocrine differentiation resulting in more immature insulinþ cells.
Thus, the presence of higher proportion of MafBþ insulinþ cells in
TTendoP5 pancreas reveals that during postnatal maturation, the loss
of MafB expression in insulinþ cells is primarily controlled by cell-
autonomous mechanisms and not by cell-extrinsic mechanisms that
depend on parturition and/or nutritional state of the pup.
Discussion
Our results demonstrate that precocious MafA expression in
Ngn3-expressing cells is detrimental to endocrine differentiation.
The point of impact of such MafA expression on the ontogenic
program is most likely after the endocrine progenitor commits to a
speciﬁc hormone-expressing fate. Importantly, these cells are in
stasis: when the MafA block is released, cells move forward,
apparently towards full differentiation. Delaying the initiation of
endocrine differentiation by forced expression of MafA also showed
that the transition from MafAþMafBþ insulinþ to MafAþMafB
insulinþ cells is regulated by cell-intrinsic mechanisms. Our study
thus demonstrates the importance of precise timing of transcription
factor expression on the normal progression of cell differentiation,
as well as a novel approach to explore the timing of MafA
expression as a driver of β-cell differentiation and maturation.
Unlike other endocrine transcription factors, MafA expression
in endocrine progenitors inhibits endocrine differentiation. Ngn3
promoter-driven Nkx6.1 expression in endocrine progenitors
altered neither the proportion nor number of α- and β-cells
(Nelson et al., 2007). Similar to MafA, initiation of Pdx1 expression
in the β-cell lineage occurs after insulin expression (Artner et al.,
2006; Nishimura et al., 2006). Yet, precocious Pdx1 expression in
endocrine progenitors did not halt their differentiation, rather it
resulted at birth in Pdx1highglucagonþ cells that by P12 differ-
entiated into insulinþ cells (Yang et al., 2011). Furthermore, the
inhibition of endocrine differentiation by precocious MafA expres-
sion may not be due to incompatibility between Maf factors and
differentiation of Ngn3þ cells, as MafBþNgn3þhormone cells are
seen during endocrine differentiation (Artner et al., 2006). These
observations suggest that precocious/enhanced expression of
endocrine transcription factors in Ngn3þ cells does not itself
inhibit endocrine differentiation.
Mice with loss of function mutations in some transcription
factor genes, including MafB, Nkx6.1 and NeuroD1, show a reduc-
tion in endocrine cells, while the loss of function of genes for
Nkx2.2, Pax6, Pax4 and Arx alters the fate of endocrine cells (Gittes,
2009; Pan and Wright, 2011). Thus, the phenotype of TTendo mice
cannot simply be explained by MafA inhibiting expression of a
single endocrine transcription factor. The precise identiﬁcation of
the mechanism underlying this action of MafA will require
detailed analyses of embryonic TTendo pancreas, including assess-
ment of expression of key endocrine transcription factors.
Together these results suggest that similar to the unique
characteristics of precocious Pdx1 expression in endocrine pro-
genitors that permits conversion of α-cells into β-cells (Yang et al.,
2011), MafAMyc in endocrine progenitors uniquely blocks endo-
crine differentiation. Furthermore, our results support the possi-
bility that the MafA/MafB pair is logically interconnected to
regulate speciﬁcation and maturation of β-cells in order to mini-
mize potential risks of MafA-mediated inhibition of endocrine
differentiation during embryonic development.
Multiple lines of evidence support that MafAMyc expression in
endocrine progenitors blocked their differentiation after commit-
ment to hormone-expressing state rather than inhibiting the
initial stages of endocrine differentiation. At E15.5 we detected
both Ngn3þ cells and MafAMycþ cells (Fig. 3). Unlike in the Ngn3 /
pancreas (Beucher et al., 2012; Magenheim et al., 2011), in TTendo
pancreas tubular epithelium appeared normal, and lineage-marked
(GFPþ , MafAMycþ) hormone cells were found in small islet-like
clusters and were not restricted to the tubules (Fig. 2). These ﬁndings
suggest that MafAMyc expression in endocrine progenitors did not
affect lateral inhibition or impede Ngn3 expression in progenitors nor
prevented their movement from tubular epithelium to form islet
clusters (Gouzi et al., 2011; Pan and Wright, 2011). Additionally, the
comparable proportion of Ngn3þ cells (Supplementary Fig. 1) and
ChrgAþ endocrine cells in control and TTendo pancreas (Fig. 3)
supports the idea that MafAMyc misexpression blocked endocrine
differentiation after its initiation but before induction of hormone
expression. Consistent with this, removing the MafAMyc inﬂuence by
DOX withdrawal at E15.5 allowed ChrgAþhormone cells to resume
their differentiation into hormoneþ cells (Figs. 4,5).
The restriction of competence of pancreatic epithelium to
differentiate into α-cells primarily before E14.5 (Johansson et al.,
2007) would predict that releasing the block on MafAMycþ cells
after E15.5 should yield fewer α-cells. However, this release had no
preferential reduction of α-cells, and the pancreas showed com-
parable proportion of lineage-marked α- and β- cells as controls
(Figs. 4–6), indicating that the formation of hormoneþ cells,
including α-cells, resulted from these cells resuming their speci-
ﬁed differentiation. These data support the conclusion that pre-
cocious MafA expression blocks endocrine differentiation after the
cells acquired a speciﬁc hormonal fate but before induction of
hormone expression. Additional analyses, including demonstra-
tion that single ChrgAþhormone cell give rise to a cluster of cells
expressing the same hormone, will be required to conﬁrm this
conclusion.
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The steps involved in the conversion of Ngn3þ endocrine
progenitors to MafBhighinsulinþ cells and their subsequent matura-
tion to MafBMafAþ insulinþ cells, are presently still poorly under-
stood. We suggest thatMafA pause/release experiments will address
a critical scientiﬁc gap in our understanding of differentiation and
maturation of β-cells. DOX-regulated Pdx1 expression in Pdx1 /
pancreas showed distinct roles for Pdx1 at morphologically distinct
stages of development (Hale et al., 2005). Our MafA-induced pause/
release manipulation similarly provides a novel way to evaluate
terminal steps in endocrine differentiation including transition from
MafB to MafA expression, as well as what triggers the induction and
inhibition of these factors during development. Its key advantages
are that: (1) the resumption of differentiation can be delayed to
discriminate between regulation by cell-intrinsic mechanisms and
environmental cues and (2) Ngn3þ cells rapidly induce hormone
expression (24–34 h, Beucher et al., 2012), so delaying re-initiation
of differentiation by several days will potentially result in a
synchronized population of cells, providing a novel means to
identify the steps involved in terminal differentiation of endocrine
progenitors and their conversion into mature β-cells. Using this
approach we showed that the loss of MafB expression in insulinþ
cells after birth is under the control of cell intrinsic mechanisms
(Fig. 6). This observation raises the possibility that mechanisms
underlying the loss of MafB expression during transition of rodent
β-cells from insulinþMafBþMafAþ to insulinþMafBMafAþ might
be impaired in human β-cells, which will result in adult human β-
cells expressing both MafB and MafA.
Forced MafA expression has important implications for gener-
ating functional β-cells. Protocols for differentiating ES/iPS cells to
insulinþ cells in vitro have resulted in cells with impaired glucose-
stimulated insulin secretion and low MafA expression. Yet the
detrimental effects of precocious MafA expression in pancreatic
(Nishimura et al., 2009) and endocrine progenitors (this study)
caution the use of forced MafA expression to drive maturation of
these insulinþ cells. Surprisingly, MafA was required for repro-
gramming adult liver and acinar cells into insulinþ cells (Kaneto
et al., 2005; Zhou et al., 2008), but these reprogrammed insulinþ
cells had limited glucose-responsiveness, suggesting that out of
normal embryonic context, forced expression of MafA impairs
terminal differentiation/maturation of transdifferentiated β-cells
or that such cells require a different mechanism for maturation
than embryonic β-cells.
In summary, our results provide a rationale for the sequence of
transcription factor activation during normal pancreas organogen-
esis with MafA expression initiated only after that of insulin. They
further suggest why approaches inducing MafA expression at or
before the endocrine progenitor stage in stem/progenitor cell
differentiation would be detrimental to glucose-responsive β-cell
formation. We provided evidence of a novel MafA pause/release
approach that can be used to study terminal steps of endocrine
differentiation. Using this approach we showed the loss of MafB
expression in maturing insulinþ cells depends on cell-autonomous
mechanisms. Future use of this approach can characterize the
endocrine differentiation of a potentially synchronized population
of committed insulin precursors, deﬁning the steps these precursors
take to become mature insulinþMafAþMafB cells and identifying
intracellular signal transduction pathways regulating MafB and
MafA expression during β-cell maturation.
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